CAC
Cowen and Company’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,700
| Closed | -$364K | – | 66 |
|
|
2024
Q3 | $364K | Buy |
+10,700
| New | +$364K | 0.01% | 178 |
|
|
2022
Q1 | – | Sell |
-466,591
| Closed | -$18M | – | 511 |
|
|
2021
Q4 | $18M | Sell |
466,591
-182,687
| -28% | -$7.06M | 1.64% | 15 |
|
|
2021
Q3 | $35.1M | Buy |
649,278
+620,883
| +2,187% | +$33.5M | 1.66% | 15 |
|
|
2021
Q2 | $950K | Buy |
+28,395
| New | +$950K | 0.05% | 129 |
|